Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea



Status:Completed
Conditions:Cosmetic, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:May 2014
End Date:December 2014

Use our guide to learn which trials are right for you!

This study will evaluate the safety and efficacy of AGN-199201 once daily compared to
vehicle for the treatment of persistent moderate to severe facial erythema associated with
rosacea.


Inclusion Criteria:

-Moderate to severe persistent facial erythema associated with rosacea.

Exclusion Criteria:

- Greater than 3 inflammatory lesions on the face

- Current treatment with monoamine oxidase (MAO) inhibitors

- Raynaud's syndrome, narrow angle glaucoma, orthostatic hypotension, scleroderma or
Sjogren's syndrome.
We found this trial at
1
site
?
mi
from
Lynchburg, VA
Click here to add this to my saved trials